[TAK]
Mid
Mid
2026-08-29 07:58:00
FDA approves Takeda’s Mimrylo for polycythemia vera treatment
Mid
2026-08-29 06:48:17
Takeda gains approval of rusfertide for polycythemia vera
Row
2026-07-30 15:55:30
Takeda Pharmaceutical reports Q1 results
Row
2026-07-13 20:36:12
Form 144 Takeda Pharmaceutical Company Limited For: 13 July
Row
2026-07-13 20:36:10
Form 144 Takeda Pharmaceutical Company Limited For: 13 July
1 / 2